Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Eligible medications: Wegovy (semaglutide), Zepbound (tirzepatide), and Foundayo (orforglipron)
As opposed to common treatment agents such as insulin and sulphonylureas, GLP-1-based treatment has been associated with weight loss and a lower risk of hypoglycemia, two important considerations for patients with type 2 diabetes
External resources STEP 1 Trial: Semaglutide in Adults with Overweight or Obesity (NEJM) SURMOUNT-1 Trial: Tirzepatide for Treatment of Obesity (NEJM) NIH BMI Calculator (National Heart, Lung, and Blood Institute) For researchers serious about navigating GLP-1 eligibility and optimizing their treatment protocols, SeekPeptides offers the most comprehensive resource available
Follow the reconstitution guide carefully, store properly at 28C after reconstitution, and use our reconstitution calculator to ensure accurate dosing so you're not over-injecting
Simply use the form below and send a note to an agent advisor or call (518) 346-2115
This helps a person eat less, and it is used alongside a reduced-calorie diet and increased physical activity in adults
US$ 26.70
US$ 20.05
US$ 27.21
US$ 27.71
